Diagnostics

How ARUK is working to address major gaps in dementia research

Using plasma biomarkers in the diagnosis of Alzheimer’s disease

Which plasma biomarkers hold the most promise in Alzheimer’s Disease?

Blood-based biomarkers for Alzheimer’s disease screening

The use of technology in the early detection of dementia

Latest developments in imaging biomarkers for dementia: PET-MRI scans

The EDoN initiative: Early Detection of Neurodegenerative diseases

PET-MRI and machine learning

Mass spectrometry-based proteomics identifies progressive changes in tau PTMs over time

Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s

Diagnosing dementia in low educated and indigenous populations

Antibodies as research tools to study dementia

Microglia associated with longevity and a lower AD risk

The development of oligomer-specific antibodies and their potential use as a diagnostic tool

Hopes and challenges in AD research

The impact of antibodies use on biomedical research